Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life

BACKGROUND: The purpose of this study was to assess visual function and vision-related quality of life after intravitreal injection of ranibizumab (IVR) using a pro re nata regimen for the treatment of age-related macular degeneration. METHODS: A prospective study of 54 eyes in 54 patients scheduled...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Maiko, Arakawa, Akira, Yamane, Shin, Kadonosono, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160327/
https://www.ncbi.nlm.nih.gov/pubmed/25228787
http://dx.doi.org/10.2147/OPTH.S68293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160327/
https://www.ncbi.nlm.nih.gov/pubmed/25228787
http://dx.doi.org/10.2147/OPTH.S68293

Ejemplares similares